XT
KTTA icon

XTX Topco’s Pasithea Therapeutics KTTA Stock Holding History

XTX Topco’s Portfolio KTTA Stock Details KTTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.8K Buy
127,572
+93,821
+278% +$64.5K ﹤0.01% 3644
2026
Q1 		$25K Buy
33,751
+12,968
+62% +$10.8K ﹤0.01% 3495
2025
Q4 		$26.8K Sell
20,783
-13,575
-40% -$11.9K ﹤0.01% 2993
2025
Q3 		$24.7K Buy
+34,358
New +$25.1K ﹤0.01% 2290
2023
Q4 		– Sell
-536
Closed -$5.14K – 1862
2023
Q3 		$5.14K Buy
+536
New +$5.87K ﹤0.01% 1462

Other funds holding KTTA

CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return

XTX Topco's KTTA Position: Q2 2026 in Review

XTX Topco increased its Pasithea Therapeutics (KTTA) stake by 278% in Q2 2026, buying an estimated $64.5K and bringing the position to 127,572 shares worth $65.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3644.

XTX Topco first reported a position in KTTA in Q3 2023 and has held it in 5 quarters since. 25 funds tracked by Wall St. Rank hold KTTA as of Q2 2026.

  • XTX Topco held 127,572 shares of Pasithea Therapeutics worth $65.8K as of Q2 2026.
  • XTX Topco bought 93,821 Pasithea Therapeutics shares in Q2 2026, an estimated $64.5K.
  • Pasithea Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3644 holding.
  • XTX Topco first reported a position in Pasithea Therapeutics in Q3 2023 and has held it in 5 quarters since.
  • 25 funds tracked by Wall St. Rank held Pasithea Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.